Taxpayers paid to develop remdesivir but will have no say when Gilead sets the price
Critics say the government deserves more credit for tens of millions in public money spent to develop the coronavirus treatment. More
VIDEO: Are hospitals collaborating during Covid-19?
During this unprecedented health crisis, what will it take for hospitals to put aside their rivalries and work together? Shannon Brownlee and Vikas Saini discuss in the latest edition of "Lown Hospitals Q&A." More
Wealthiest Hospitals Got Billions in Bailout for Struggling Health Providers
Twenty large chains received more than $5 billion in federal grants even while sitting on more than $100 billion in cash. More
COVID-Like Cough Sent Him To ER — Where He Got A $3,278 Bill
A dad in Denver tried to do everything right when COVID symptoms surfaced. Still, he ended up with a huge bill from an insurer that had said it waived cost sharing for coronavirus treatment. More
The Public Has Been Forgiving. But Hospitals Got Some Things Wrong.
Mistakes are inevitable. But we can try to do better. More
How A Company Misappropriated Native American Culture To Sell Health Insurance
Maine investigators find one patient’s saga with O’NA HealthCare offers a cautionary tale for anyone looking for cut-rate coverage online. More
Amid conflict-of-interest criticisms, top FDA officials recuse themselves from Covid-19 vaccine approvals
Two top FDA officials will recuse themselves from Covid-19 vaccine approval decisions since they are joining a Trump push for approval. More
Covid-19 has exposed the limits of the pharmaceutical market model
Remdesivir is the poster child for why we need a new model of drug development for pandemics and neglected diseases that isn't market-based. More
Medicaid Providers At The End Of The Line For Federal COVID Funding
Congress authorized $100 billion for health care providers, both to compensate them for the extra costs associated with caring for patients with COVID-19 and for the revenue that’s not coming in from regular care. They have been required to stop providing most nonemergency services, and many patients are afraid to visit health care facilities. More
If J&J really wants to support nurses, it should make the TB drug bedaquiline affordable
Bedaquiline, an important treatment for tuberculosis, costs too much for most people. Johnson & Johnson could sell it for $1 a day and still turn a profit. More
‘They killed her’: Why are breast implants still putting millions of women at risk?
Allergan’s “medical aesthetics” products helped persuade AbbVie to buy the company. But what if the devices driving profit are also endangering women’s health? More
Hospitals Knew How to Make Money. Then Coronavirus Happened.
Surgeries are canceled. Business models are shifting. Some of the hardest-hit hospitals may close, leaving patients with fewer options for care. More
The Nonprofit Grifters Who Want a Cut of the Coronavirus Bailout
After years of undermining health policy to aid their Big Pharma patrons, patient advocacy groups are making claims to federal pandemic relief. More
Hospital workers complain of minimal disclosure after COVID exposures
The disconnect between hospital policy and worker expectations often centers around the lack of clear, direct communication with individual workers who have been potentially exposed to the coronavirus. More
Pandemic spawns new spirit of collaboration for Boston’s longtime rival hospitals
Hospitals have been sharing supplies, equipment, data, and even staff as they scramble to treat patients sick with COVID-19, the disease caused by the coronavirus. More
One Hospital System’s Response to Covid-19? Union-Busting.
Administrators across the country are increasingly turning to anti-labor consultants to fend off nurses’ unions. More
Hospital CEOs take pay cuts amid COVID-19
As losses mount, hospital chains like Advocate Aurora Health, Providence and Loyola Medicine have had to trim costs—including at the top. More
Commercial Influences on Electronic Health Records and Adverse Effects on Clinical Decision Making
This Viewpoint describes how the clinical decision support tools that are part of electronic health records and are used by physicians may be corrupted by commercial influence. More
Florida oncology network that bilked cancer patients gets $67 million in COVID-19 aid
Florida Cancer Specialists said that coronavirus relief dollars from taxpayers will not be used to pay back their fines. More
As Hospitals Lose Revenue, More Than A Million Health Care Workers Lose Jobs
Faced with lost revenue from canceled elective procedures, hospitals laid off 1.4 million health care workers in April, including nearly 135,000 from hospitals. More